Enrique I. J.
- Country
- Spain
- Department
- Internal Medicine
Research Overview
- Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of IMVT-1402 Efficacy and Safety in Active Subacute and Chronic Cutaneous Lupus Erythematosus: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 5 of 368 partner sites.
Specializations
Cardiovascular Research
This investigator specializes in atherosclerotic cardiovascular disease (ASCVD) research, with particular emphasis on preventive cardiology and therapeutic interventions for patients with established vascular conditions.
- Cardiovascular mortality prevention
- Atherosclerosis management
- Stroke prevention strategies
Their research focus includes investigating innovative approaches for reducing major adverse cardiovascular events in high-risk populations.
Lipid Management
The investigator demonstrates expertise in lipid disorder treatments and their relationship to cardiovascular outcomes, particularly in patients with elevated LDL cholesterol levels.
- Lipid-lowering therapies
- Cholesterol management
- Preventive cardiology
Their work explores therapeutic solutions for patients requiring additional lipid management beyond conventional treatments.
Vascular Medicine
The investigator focuses on vascular disease management and its complications, including comprehensive approaches to preventing adverse cardiovascular outcomes.
- Vascular disease prevention
- Cardiovascular risk reduction
- Heart attack prevention
Their research encompasses therapeutic strategies for patients with established vascular conditions requiring secondary prevention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.